Kate E. Broderick

6.4k total citations
93 papers, 2.7k citations indexed

About

Kate E. Broderick is a scholar working on Immunology, Biotechnology and Epidemiology. According to data from OpenAlex, Kate E. Broderick has authored 93 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 28 papers in Biotechnology and 19 papers in Epidemiology. Recurrent topics in Kate E. Broderick's work include Transgenic Plants and Applications (25 papers), Microbial Inactivation Methods (23 papers) and Immunotherapy and Immune Responses (17 papers). Kate E. Broderick is often cited by papers focused on Transgenic Plants and Applications (25 papers), Microbial Inactivation Methods (23 papers) and Immunotherapy and Immune Responses (17 papers). Kate E. Broderick collaborates with scholars based in United States, United Kingdom and Canada. Kate E. Broderick's co-authors include Niranjan Y. Sardesai, Julian A. T. Dow, Shireen A. Davies, David B. Weiner, Laurent Humeau, Laura Kean, Amir Sada Khan, Trevor R.F. Smith, Valerie P. Pollock and Jian Yan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kate E. Broderick

93 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kate E. Broderick United States	30	925	871	539	475	446	93	2.7k
Germain J. P. Fernando Australia	40	2.1k 2.2×	1.0k 1.2×	351 0.7×	917 1.9×	193 0.4×	91	4.2k
Wolfgang W. Leitner United States	27	1.9k 2.0×	2.4k 2.8×	567 1.1×	668 1.4×	124 0.3×	82	4.7k
Nicole N. van der Wel Netherlands	36	1.3k 1.4×	1.9k 2.1×	1.6k 2.9×	1.5k 3.2×	169 0.4×	92	5.0k
David Kobiler Israel	31	382 0.4×	1.4k 1.7×	832 1.5×	175 0.4×	141 0.3×	76	2.5k
Brigitte G. Dorner Germany	28	1.9k 2.1×	717 0.8×	247 0.5×	448 0.9×	301 0.7×	79	3.2k
W.J.A. Boersma Netherlands	38	839 0.9×	1.2k 1.4×	462 0.9×	397 0.8×	53 0.1×	105	4.2k
Joseph G. Joyce United States	26	1.0k 1.1×	1.2k 1.4×	539 1.0×	1.2k 2.5×	117 0.3×	59	3.2k
Kimmo Virtaneva United States	31	689 0.7×	1.2k 1.4×	1.3k 2.3×	794 1.7×	121 0.3×	55	4.5k
Christopher K. E. Bleck United States	30	600 0.6×	1.6k 1.9×	1.1k 2.0×	759 1.6×	87 0.2×	71	4.0k
Agathe Subtil France	34	666 0.7×	1.6k 1.9×	358 0.7×	666 1.4×	89 0.2×	59	3.3k

Countries citing papers authored by Kate E. Broderick

Since Specialization

Citations

This map shows the geographic impact of Kate E. Broderick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate E. Broderick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate E. Broderick more than expected).

Fields of papers citing papers by Kate E. Broderick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate E. Broderick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate E. Broderick. The network helps show where Kate E. Broderick may publish in the future.

Co-authorship network of co-authors of Kate E. Broderick

This figure shows the co-authorship network connecting the top 25 collaborators of Kate E. Broderick. A scholar is included among the top collaborators of Kate E. Broderick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate E. Broderick. Kate E. Broderick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Henderson, Jordana M., Christoph Vo, Nona Abolhassani, et al.. (2025). CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA. Molecular Therapy — Nucleic Acids. 36(1). 102456–102456. 2 indexed citations

Generotti, Alison, Dustin Elwood, Katherine Schultheis, et al.. (2023). Intradermal DNA vaccine delivery using vacuum-controlled, needle-free electroporation. Molecular Therapy — Nucleic Acids. 34. 102070–102070. 9 indexed citations

Riddell, Shane, Sarah Goldie, Alexander J. McAuley, et al.. (2021). Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets. Frontiers in Immunology. 12. 694857–694857. 6 indexed citations

Walker, Susanne N., Neethu Chokkalingam, Emma L. Reuschel, et al.. (2020). SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients. Journal of Clinical Microbiology. 58(11). 42 indexed citations

Xu, Ziyang, Neethu Chokkalingam, Edgar Tello‐Ruiz, et al.. (2020). A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control. Cancer Immunology Research. 8(11). 1354–1364. 21 indexed citations

Rosati, Margherita, Kate E. Broderick, Mark G. Lewis, et al.. (2020). Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques. PLoS ONE. 15(3). e0228163–e0228163. 3 indexed citations

Schultheis, Katherine, Holly Pugh, Bryan S. Yung, et al.. (2019). Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination. Journal of Visualized Experiments. 2 indexed citations

Yung, Bryan S., Katherine Schultheis, Kar Muthumani, et al.. (2019). Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation. Human Gene Therapy. 30(4). 523–533. 8 indexed citations

Jiang, Jing‐Jing, Stephanie Ramos, Paul D. Fisher, et al.. (2019). Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses. Vaccine. 37(29). 3832–3839. 18 indexed citations

10.

Duperret, Elizabeth K., Regina Stoltz, Ami Patel, et al.. (2018). Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti–CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo. Cancer Research. 78(22). 6363–6370. 49 indexed citations

11.

Fisher, Paul D., William B. Kiosses, Janess Mendoza, et al.. (2017). Adipose tissue: a new target for electroporation-enhanced DNA vaccines. Gene Therapy. 24(12). 757–767. 13 indexed citations

12.

Hu, Xintao, Antonio Valentin, Viraj Kulkarni, et al.. (2016). DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. The Journal of Immunology. 197(10). 3999–4013. 29 indexed citations

13.

Broderick, Kate E., Amir Sada Khan, & Niranjan Y. Sardesai. (2014). DNA Vaccination in Skin Enhanced by Electroporation. Methods in molecular biology. 1143. 123–130. 14 indexed citations

14.

Smith, Trevor R.F., Katherine Schultheis, William B. Kiosses, et al.. (2014). DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response. Molecular Therapy — Methods & Clinical Development. 1. 14054–14054. 25 indexed citations

15.

Muthumani, Kar, Megan C. Wise, Kate E. Broderick, et al.. (2013). HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo. PLoS ONE. 8(12). e84234–e84234. 21 indexed citations

16.

Bagarazzi, Mark L., Jian Yan, Matthew P. Morrow, et al.. (2012). Immunotherapy Against HPV16/18 Generates Potent T _H 1 and Cytotoxic Cellular Immune Responses. Science Translational Medicine. 4(155). 155ra138–155ra138. 229 indexed citations

17.

Jalah, Rashmi, Vainav Patel, Viraj Kulkarni, et al.. (2012). IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques. Human Vaccines & Immunotherapeutics. 8(11). 1620–1629. 54 indexed citations

18.

Lin, Feng, Xuefei Shen, Janess Mendoza, et al.. (2011). A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Vaccine. 29(39). 6771–6780. 45 indexed citations

19.

Broderick, Kate E., Shunhui Zhuang, Jeffrey C. Chen, et al.. (2005). Nitric Oxide Scavenging by the Cobalamin Precursor Cobinamide. Journal of Biological Chemistry. 280(10). 8678–8685. 58 indexed citations

20.

Weinman, Jeremy J., Michael A. Djordjevic, E. H. Creaser, et al.. (1995). Preparing subterranean clovers for future biotechnology: molecular analysis of genes and proteins involved in stress and defence reactions and the construction of transgenic plants.. Plant protection quarterly. 10(2). 47–49. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact